Engineering Research Center of Key Technology and Industrialization of Cell-based Vaccine, Ministry of Education, Biomedical Research Center, Northwest Minzu University, Lanzhou, 730030, China; Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, 730030, Lanzhou, China; College of Veterinary Medicine, Gansu Agricultural University, 730030, Lanzhou, China; Department of Experiment & Teaching, Northwest Minzu University, 730030, Lanzhou, China.
Engineering Research Center of Key Technology and Industrialization of Cell-based Vaccine, Ministry of Education, Biomedical Research Center, Northwest Minzu University, Lanzhou, 730030, China; Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, 730030, Lanzhou, China.
Biologicals. 2023 Aug;83:101699. doi: 10.1016/j.biologicals.2023.101699. Epub 2023 Aug 11.
Influenza is an acute respiratory infectious disease caused by influenza virus that seriously endangers people's health. Influenza vaccination is the most effective means to prevent influenza virus infection and its serious complications. MDCK cells are considered to be superior to chicken embryos for the production of influenza vaccines, but the tumorigenicity of cells is a concern over the theoretical possibility of the risk of adverse events. The theoretical risks need to be adequately addressed if public confidence in programs of immunization are to be maintained. In this paper, studies of the tumorigenic potential of cell lines, with MDCK cells as an example, published since 2010 are reviewed. The mechanism of tumorigenicity of MDCK cells is discussed with reference to cell heterogeneity and epithelial to mesenchymal transition (EMT). Understanding the mechanism of the acquisition of a tumorigenic phenotype by MDCK cells might assist in estimating potential risks associated with using tumorigenic cell substrates for vaccine production.
流感是由流感病毒引起的急性呼吸道传染病,严重危害人民健康。流感疫苗接种是预防流感病毒感染及其严重并发症的最有效手段。MDCK 细胞被认为比鸡胚更适合生产流感疫苗,但细胞的致瘤性是人们担心的理论上存在不良事件风险的可能性。如果要维持公众对免疫接种计划的信心,就需要充分应对这些理论风险。本文综述了 2010 年以来发表的关于细胞系致瘤性潜力的研究,以 MDCK 细胞为例。参考细胞异质性和上皮间质转化(EMT)讨论了 MDCK 细胞致瘤性的机制。了解 MDCK 细胞获得致瘤表型的机制可能有助于评估使用致瘤细胞基质生产疫苗相关的潜在风险。